首页> 外文期刊>World Journal of Gastroenterology >Effect of intraoperative radiotherapy combined with external beam radiotherapy following internal drainage for advanced pancreatic carcinoma
【24h】

Effect of intraoperative radiotherapy combined with external beam radiotherapy following internal drainage for advanced pancreatic carcinoma

机译:内引流术后术中放疗联合外照射对晚期胰腺癌的疗效

获取原文
获取原文并翻译 | 示例
           

摘要

AIM: To determine the survival of advanced pancreatic cancer patients treated with intraoperative radiotherapy (IORT) combined with external beam radiation therapy (EBRT) following internal drainage (cholecystojejunostomy or choledochojejunostomy). METHODS: Eighty-one patients with advanced pancreatic cancer who received IORT combined with EBRT following internal drainage (ID) between 1996 and 2001 were retrospectively analyzed. Among the 81 patients, 18 underwent ID+IORT, 25 ID+IORT+EBRT (meanwhile, given 5-Fu 300 mg/m~2 iv drip, 2f/w), 16 EBRT, 22 had undergone simple internal drainage. The IORT dose was 15-25Gy in a single fraction. The usual EBRT dose was 30-40Gy with a daily fraction of 1.8-2.0 Gy. RESULTS: The complete remission rate, partial remission rate of patients with backache and abdominal pain treated with ID+IORT were 55.5%, 33.3% respectively. Alleviation of pain was observed 2 or 3 wk after IORT. The median survival time (MST) of ID+IORT group was 10.7 mo. The pain remission rate of patients treated with ID+IORT+EBRT was 92%, and their MST was 12.2 mo. The MST of patients treated with EBRT and simple internal drainage was 5.1 mo and 7.0 mo, respectively. The survival curve of ID+IORT. group and ID+IORT+EBRT group was significantly better than that of EBRT group (P<0.05). The difference between the ID+IORT+EBRT group and ID group was significant (P<0.05). CONCLUSION: IORT combined with EBRT following internal drainage can alleviate pain, improve quality of life and prolong survival time of patients with advanced pancreatic cancer.
机译:目的:确定在内部引流(胆囊空肠吻合术或胆总管空肠吻合术)后接受术中放疗(IORT)联合外照射治疗(EBRT)治疗的晚期胰腺癌患者的生存率。方法:回顾性分析1996年至2001年间经内引流(ID)后接受IORT联合EBRT的81例晚期胰腺癌患者。在81例患者中,有18例接受了ID + IORT,25例进行了ID + IORT + EBRT(同时,给予5-Fu 300 mg / m〜2 iv滴注,剂量为2f / w),其中16例接受了EBRT,其中22例接受了简单的内部引流。 IORT剂量为15-25Gy。常用的EBRT剂量为30-40Gy,每日剂量为1.8-2.0 Gy。结果:ID + IORT治疗的腰酸和腹痛患者的完全缓解率,部分缓解率分别为55.5%,33.3%。 IORT后2或3周观察到疼痛减轻。 ID + IORT组的中位生存时间(MST)为10.7 mo。 ID + IORT + EBRT治疗的患者疼痛缓解率为92%,MST为12.2 mo。 EBRT和单纯内部引流治疗的患者的MST分别为5.1 mo和7.0 mo。 ID + IORT的生存曲线。 ID + IORT + EBRT组明显优于EBRT组(P <0.05)。 ID + IORT + EBRT组与ID组差异有统计学意义(P <0.05)。结论:内引流后IORT联合EBRT可减轻晚期胰腺癌患者的疼痛,改善生活质量,延长生存时间。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号